BIMI (BIMI) Competitors

$1.19
-0.02 (-1.65%)
(As of 04/25/2024 ET)

BIMI vs. ZKIN, COSM, MEDS, GLTO, QTI, PMCB, CCLD, ATIP, UPHL, and ZIVO

Should you be buying BIMI stock or one of its competitors? The main competitors of BIMI include ZK International Group (ZKIN), Cosmos Health (COSM), TRxADE HEALTH (MEDS), Galecto (GLTO), QT Imaging (QTI), PharmaCyte Biotech (PMCB), CareCloud (CCLD), ATI Physical Therapy (ATIP), UpHealth (UPHL), and ZIVO Bioscience (ZIVO).

BIMI vs.

ZK International Group (NASDAQ:ZKIN) and BIMI (NASDAQ:BIMI) are both small-cap basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, profitability, earnings, media sentiment, valuation, analyst recommendations, risk, institutional ownership and community ranking.

ZK International Group has a net margin of 0.00% compared to ZK International Group's net margin of -94.58%. BIMI's return on equity of 0.00% beat ZK International Group's return on equity.

Company Net Margins Return on Equity Return on Assets
ZK International GroupN/A N/A N/A
BIMI -94.58%-133.29%-33.85%

ZK International Group received 179 more outperform votes than BIMI when rated by MarketBeat users. Likewise, 63.38% of users gave ZK International Group an outperform vote while only 57.50% of users gave BIMI an outperform vote.

CompanyUnderperformOutperform
ZK International GroupOutperform Votes
225
63.38%
Underperform Votes
130
36.62%
BIMIOutperform Votes
46
57.50%
Underperform Votes
34
42.50%

In the previous week, BIMI had 2 more articles in the media than ZK International Group. MarketBeat recorded 2 mentions for BIMI and 0 mentions for ZK International Group. ZK International Group's average media sentiment score of 0.42 beat BIMI's score of 0.00 indicating that BIMI is being referred to more favorably in the news media.

Company Overall Sentiment
ZK International Group Neutral
BIMI Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ZK International Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
BIMI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

ZK International Group has higher revenue and earnings than BIMI.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ZK International Group$102.39M0.19-$6.08MN/AN/A
BIMI$12.63M1.09-$22.39MN/AN/A

ZK International Group has a beta of 2.13, meaning that its stock price is 113% more volatile than the S&P 500. Comparatively, BIMI has a beta of 1.58, meaning that its stock price is 58% more volatile than the S&P 500.

0.3% of ZK International Group shares are owned by institutional investors. Comparatively, 0.1% of BIMI shares are owned by institutional investors. 29.8% of ZK International Group shares are owned by company insiders. Comparatively, 69.0% of BIMI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

ZK International Group beats BIMI on 9 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIMI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIMI vs. The Competition

MetricBIMIDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ Exchange
Market Cap$13.79M$15.18B$4.98B$7.44B
Dividend YieldN/A1.24%2.99%3.94%
P/E RatioN/A35.50234.3619.38
Price / Sales1.091.902,355.9190.20
Price / CashN/A10.1647.2135.26
Price / Book0.8813.134.604.27
Net Income-$22.39M$665.71M$103.03M$213.88M
7 Day Performance-11.19%2.10%-0.51%0.97%
1 Month Performance-35.68%-4.20%-6.00%-4.23%
1 Year Performance50.63%5.78%8.90%7.79%

BIMI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ZKIN
ZK International Group
0 of 5 stars
$0.64
-3.0%
N/A+25.0%$19.49M$102.39M0.00280Positive News
COSM
Cosmos Health
1.9722 of 5 stars
$0.64
-1.5%
N/A-84.9%$10.88M$50.35M0.00102Short Interest ↓
MEDS
TRxADE HEALTH
0 of 5 stars
$7.06
-3.3%
N/A+26.4%$8.51M$9.37M-1.0233Short Interest ↓
Gap Up
GLTO
Galecto
2.4491 of 5 stars
$0.68
-1.5%
$5.33
+686.2%
-65.1%$18.39MN/A-0.4713Short Interest ↓
Gap Up
QTI
QT Imaging
0 of 5 stars
$0.85
-21.3%
N/AN/A$18.22MN/A0.00N/A
PMCB
PharmaCyte Biotech
0 of 5 stars
$2.15
+1.9%
N/A-29.1%$18.17MN/A-1.792Short Interest ↓
Positive News
Gap Down
CCLD
CareCloud
2.6457 of 5 stars
$1.16
flat
$3.17
+173.0%
-67.5%$18.70M$117.06M-0.293,600Upcoming Earnings
Short Interest ↓
Positive News
Gap Down
ATIP
ATI Physical Therapy
0.532 of 5 stars
$4.29
+1.9%
N/A-69.5%$18.06M$699.02M-0.136,000Short Interest ↓
News Coverage
Gap Up
UPHL
UpHealth
0 of 5 stars
$0.96
+3.2%
N/AN/A$18.06M$130M-0.30374Gap Up
ZIVO
ZIVO Bioscience
0 of 5 stars
$6.81
-14.9%
N/AN/A$18.92M$15,850.00-1.488Gap Down

Related Companies and Tools

This page (NASDAQ:BIMI) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners